The Evaluation of a Mobile Device to Measure Ataxia With High Altitude Exposure
1 other identifier
interventional
16
1 country
1
Brief Summary
With exposure to high altitude some individuals will develop acute mountain sickness (AMS). Current evaluation of AMS can make it difficult to rule out other possible conditions. Evaluation of ataxia, as measured by the performance of a coordinated task, can aide in the correct diagnosis of AMS. The investigators have developed novel finger-tapping tasks on a mobile device to assess both reaction time and accuracy. The proposed research will evaluate the utility of this tool in assessing human acclimatization to hypoxia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2015
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2015
CompletedFirst Submitted
Initial submission to the registry
November 3, 2015
CompletedFirst Posted
Study publicly available on registry
November 9, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2016
CompletedAugust 28, 2020
August 1, 2020
4 months
November 3, 2015
August 26, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in score of a coordination test.
Coordination test will be taken at baseline and at 5 minutes, 4 and 12 hours into a simulated altitude exposure.
Secondary Outcomes (4)
Change in severity of symptoms based on questionnaire.
Symptoms questionnaire will be assessed at baseline and at 5 minutes, 4 and 12 hours into a simulated altitude exposure.
Change in score of a balance test.
Balance test will be taken at baseline and at 5 minutes, 4 and 12 hours into a simulated altitude exposure.
Change in heart rate.
Heart rate will be assessed at baseline and at 5 minutes, 4 and 12 hours into a simulated altitude exposure.
Change in pulse oxygen saturation
Pulse oxygen saturation will be assessed at baseline and at 5 minutes, 4 and 12 hours into a simulated altitude exposure.
Study Arms (3)
Moderate Hypoxia
ACTIVE COMPARATORSubjects will be exposed to moderate hypoxia and measures of balance, heart rate, pulse oxygen saturation, questionnaires, and coordination tasks will be examined at set time intervals during the hypoxic exposure.
Sham
SHAM COMPARATORSubjects will be exposed to sham and measures of balance, heart rate, pulse oxygen saturation, questionnaires, and coordination tasks will be examined at set time intervals during the hypoxic exposure.
Mild Hypoxia
ACTIVE COMPARATORSubjects will be exposed to mild hypoxia and measures of balance, heart rate, pulse oxygen saturation, questionnaires, and coordination tasks will be examined at set time intervals during the hypoxic exposure.
Interventions
Participants will complete a novel coordination task performed on an android phone.
Participants will complete a questionnaire to assess acclimatization to hypoxia.
Participants will complete a series of static stance positions to evaluate their ability to maintain balance.
Participants will have their heart rate and pulse oxygen saturation continuously monitored throughout the entire exposure.
Eligibility Criteria
You may qualify if:
- Both Male and Female Gender
- Minimum Age of 18 years
- Maximum Age of 45 years
- Have not traveled to an altitude of 3000m or higher in 3 months prior to testing
- No history of migraines or concussion
- Not Smokers
- Females must be using monophasic birth control
- Not easily claustrophobic
- English Speaking
You may not qualify if:
- Non-English speaking individuals
- Subjects younger than 18 years old or older than 45 years old
- Subjects who visit an altitude of 3000m or greater within three months prior to the study
- Subjects with a history of cardiovascular or pulmonary conditions such as; uncontrolled congestive heart failure, COPD, pulmonary hypertension, or sickle cell disease
- Subjects with a history of migraines or concussion
- Smokers
- Females not using monophasic birth control pills
- Subjects experiencing withdrawal symptoms due to abstinence from caffeine
- Easily claustrophobic individuals
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Environmental Physiology Laboratory
Vancouver, British Columbia, Canada
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Michael S Koehle, MD
University of British Columbia
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- OTHER
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Masters of Science Student
Study Record Dates
First Submitted
November 3, 2015
First Posted
November 9, 2015
Study Start
November 1, 2015
Primary Completion
March 1, 2016
Study Completion
December 1, 2016
Last Updated
August 28, 2020
Record last verified: 2020-08